Financials
- Market Capitalization 211.01 M
- Employee 36
- Founded 2009
- CEO N/A
- Website www.corbuspharma.com
- Headquarter Delaware, United States
- FIGI BBG0078PJKQ7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.38
ratio cours/chiffre d'affaires
18.82
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3583 | NBP NovaBridge Biosciences - American Depositary Shares | 1.84 USD | -2.65% | -8.46% | +12.88% | -59.20% | 212.30 M USD | ||
| 3588 | ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.92 USD | -3.63% | -7.89% | +37.74% | +116.30% | 211.17 M USD | ||
| 3591 | ANTX AN2 Therapeutics, Inc. - Common Stock | 5.58 USD | -2.79% | -4.12% | +10.93% | +398.21% | 210.57 M USD | ||
| 3592 | IMUX Immunic, Inc. - Common Stock | 15.40 USD | -5.52% | -6.55% | +18.46% | +1778.05% | 210.12 M USD |